When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.
10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.
05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an...
03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.
21-Nov-2013 - Economic uncertainty and a bleak fiscal outlook will lead to over-regulation and increased fines in the clinical trial industry, according to an economic expert at PCT.
19-Nov-2013 - CROs from across Europe and beyond have gathered in Vienna, Austria this week for Partnerships in Clinical Trials' (PCT) European congress. Outsourcing-pharma.com will be covering the show live.
18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.
18-Nov-2013 - Catalent has cut the ribbon on its Clinical Supply facility in China just months after construction began.
04-Nov-2013 - Patient recruitment firm Synexus has opened a new office in Wroclaw, Poland in the latest stage in in expansion in the country.
30-Oct-2013 - The US FDA has completed a pre-approval inspection at a Wuxi PharmaTech facility in order for the firm to manufacture a new intermediate for a client.
21-Oct-2013 - Recipharm has partnered with market entry firm FHS Unternehmensberatung to target development projects in Austria, Germany and Switzerland.
17-Oct-2013 - CMO Jubilant LifeSciences is expanding at least four of its five manufacturing plants in the US and India as growth continues.
15-Oct-2013 - Parexel has teamed up with Japanese trial management services firm Fuijitsu Systems West in an agreement that underlines the CROs eClinical growth ambitions in Asia.
14-Oct-2013 - The Cmed Group has realigned its US operations with two new offices planned to suit the geographical needs of its clients.
01-Oct-2013 - Kemwell says it hopes to attract more Western customers following the first development and manufacture contract from its new Indian facility.
30-Sep-2013 - Chinese manufacturers looking to enter European markets must improve their quality standards, according to consultancy firm Diapharm.
09-Sep-2013 - Patheon has reported increased revenue growth for Q3 2013 following the full completion of Banner and says more industry consolidation is likely.
05-Sep-2013 - Full-Service CRO PSI is expanding into Italy, South Africa and India as part of a push to gain a more global presence for clients.
02-Sep-2013 - CROs across the board saw revenue increase by more than 10% between 2011 and 2012, which was largely fuelled by Quintiles' growth, according to a new report.
02-Sep-2013 - Rapid growth in demand for pharmaceutical storage solutions could lead to Yusen working with its competitors, the firm says as it opens a 40,000m2 warehouse in Thailand.
26-Aug-2013 - IMCD Group will promote APIs made by Italian firm FIS in territories in Eastern Europe and the Southern hemisphere under a new agreement.
19-Aug-2013 - The TransCelerate BioPharma industry group has launched its clinical trial comparator network to establish a reliable means for sourcing quality drugs for clinical trials.
01-Aug-2013 - Ireland-based commercialization services firm United Drug has announced plans to buy Spanish contract pharmaceutical sales group Expansis for €12m ($15m).
31-Jul-2013 - Regulatory support encourages international clinical trials in South Africa, according to PSI who is expanding services in the region.
24-Jul-2013 - Integrated DNA Technologies (IDT) has opened a facility in Singapore in order to manufacture oligonucleotides for research companies throughout the region.
18-Jul-2013 - As GlaxoSmithKline, Bristol-Myers Squibb and Novartis are embroiled in alleged bribery and data falsification in Asia, CROs will have to a take a hard look at whether their investments in...